CRP and infection: Many factors correlated with mortality, including clinical severity (Pitt bacteraemia score, white blood cell count, C-reactive protein level), specific source (catheter-related infection), infection by specific SCCmec type (IIIA), HA-MRSA, or hVISA, infection by pathogen with higher vancomycin MIC (≥ 2 mg/L or ≥ 1.5 mg/L), teicoplanin MIC (≥ 6 mg/L, ≥ 4 mg/L, ≥ 3mg/L, ≥ 2mg/L), and daptomycin MIC (≥ 0.38 mg/L) and inappropriate initial therapy were associated with mortality (Table 3).